A recently compiled Fact.MR report, titled “Dyslipidemia Therapeutics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018-2028” provides a comprehensive analysis of the [read full press release…]
Dyslipidemia Therapeutics Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease [read full press release…]
According to a recently released Fact.MR study, revenues from dyslipidemia therapeutics market surpassed US$ 36 billion in 2018. Low-density lipoproteins held approximately two-thirds of revenues from [read full press release…]
